Overview

Botox on Vulvar Vestibulitis

Status:
Unknown status
Trial end date:
2008-06-01
Target enrollment:
0
Participant gender:
Female
Summary
The study seeks to evaluate the effect of botulinum toxin on vulvar vestibulitis (VVS) after local injection with Botox, a potential treatment to relieve patients of vulvar pain, reducing the need for painkillers, and improving the sexual quality of life of the patients.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Rigshospitalet, Denmark
Treatments:
Botulinum Toxins
Criteria
Inclusion Criteria:

- Vulvar vestibulitis

- Safe birth control

Exclusion Criteria:

- Treated earlier with Botulinum toxin

- Ongoing vulvar infection

- Age<18

- Skin disease

- Pregnancy

- Myasthenia gravis

- Amyotrophic lateral sclerosis (ALS)

- Diabetes

- Using:

- Calcium antagonists;

- Aminoglycosides;

- Magnesium sulfate;

- Systemic steroid treatment